Intro

The chapter explores recent studies on the impact of vasopressin in autism spectrum disorder, focusing on research from Stanford University and Roche Pharmaceuticals. It presents contrasting findings on whether vasopressin administration or receptor blockade could enhance social responses in children with autism, emphasizing the individualized nature of autism treatment.